PZ-601

Protez Pharmaceuticals, Inc. · Phase 2 active Small molecule

At a glance

Generic name	PZ-601
Sponsor	Protez Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PZ-601 CI brief — competitive landscape report
PZ-601 updates RSS · CI watch RSS
Protez Pharmaceuticals, Inc. portfolio CI